Pages that link to "Q37439512"
Jump to navigation
Jump to search
The following pages link to Pharmacokinetics and 48-week safety and antiviral activity of fosamprenavir-containing regimens in HIV-infected 2- to 18-year-old children (Q37439512):
Displayed 5 items.
- PRINCE-1: safety and efficacy of atazanavir powder and ritonavir liquid in HIV-1-infected antiretroviral-naïve and -experienced infants and children aged ≥3 months to <6 years (Q35722000) (← links)
- Treatment-Emergent Mutations and Resistance in HIV-Infected Children Treated with Fosamprenavir-Containing Antiretroviral Regimens (Q35792853) (← links)
- Adverse events associated with abacavir use in HIV-infected children and adolescents: a systematic review and meta-analysis (Q38723580) (← links)
- Frequencies of immune hypersensitivity reaction-associated HLA class I alleles in healthy South African Indian and mixed ancestry populations determined by a novel real-time PCR assay. (Q43453078) (← links)
- Advances in Pediatric Pharmacology, Therapeutics, and Toxicology. (Q54194778) (← links)